Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges

Title
Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges
Authors
Keywords
Non-small-cell lung cancer, Immune checkpoint inhibitor, Pembrolizumab, Nivolumab, Atezolizumab, PDL1, PD1
Journal
EUROPEAN JOURNAL OF CANCER
Volume 78, Issue -, Pages 16-23
Publisher
Elsevier BV
Online
2017-04-11
DOI
10.1016/j.ejca.2016.12.041

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started